CH569732A5 - - Google Patents

Info

Publication number
CH569732A5
CH569732A5 CH450174A CH450174A CH569732A5 CH 569732 A5 CH569732 A5 CH 569732A5 CH 450174 A CH450174 A CH 450174A CH 450174 A CH450174 A CH 450174A CH 569732 A5 CH569732 A5 CH 569732A5
Authority
CH
Switzerland
Application number
CH450174A
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH569732A5 publication Critical patent/CH569732A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH450174A 1970-06-05 1971-06-02 CH569732A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH569732A5 true CH569732A5 (enExample) 1975-11-28

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH450174A CH569732A5 (enExample) 1970-06-05 1971-06-02
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Country Status (10)

Country Link
US (1) US3984555A (enExample)
AT (3) AT318628B (enExample)
BE (1) BE768137A (enExample)
CA (1) CA951319A (enExample)
CH (3) CH569732A5 (enExample)
DE (1) DE2027645A1 (enExample)
FR (1) FR2100726B1 (enExample)
GB (1) GB1331522A (enExample)
LU (1) LU63267A1 (enExample)
NL (1) NL7107695A (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
US5972929A (en) * 1997-08-21 1999-10-26 Shiseido Co., Ltd. Quinazolinone derivative, hair growth promoter and external composition for skin using the same
EP1216242A1 (en) 1999-10-01 2002-06-26 Advanced Medicine, Inc. Macrocyclic quinazolinones and their use as local anesthetics
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
EP1278748B1 (en) * 2000-04-25 2011-03-23 ICOS Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
EP2340838A1 (en) 2001-09-05 2011-07-06 Minerva Biotechnologies Corporation Compositions and Methods of Treatment of Cancer
US20030119834A1 (en) * 2001-09-05 2003-06-26 Bamdad Cynthia C. Compositions and methods of treatment of cancer
JP2005511581A (ja) * 2001-11-07 2005-04-28 メルク エンド カムパニー インコーポレーテッド 有糸分裂キネシン阻害剤
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
US20060052345A1 (en) * 2002-11-04 2006-03-09 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
WO2004111014A1 (en) * 2003-06-06 2004-12-23 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives as modulators of atp-binding cassette transporters
WO2005016348A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Method of inhibiting immune responses stimulated by an endogenous factor
WO2005016349A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Methods of inhibiting leukocyte accumulation
CN102229609A (zh) 2004-05-13 2011-11-02 艾科斯有限公司 作为人磷脂酰肌醇3-激酶δ抑制剂的喹唑啉酮
WO2005117889A1 (en) * 2004-05-25 2005-12-15 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic
WO2006089106A2 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
EP2233472B1 (en) * 2006-03-28 2014-01-15 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US20100202963A1 (en) 2008-11-13 2010-08-12 Gallatin W Michael Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
CA2759724A1 (en) * 2009-04-20 2010-10-28 Calistoga Pharmaceuticals, Inc. Methods of treatment for solid tumors
WO2011011550A1 (en) 2009-07-21 2011-01-27 Calistoga Pharmaceuticals Inc. Treatment of liver disorders with pi3k inhibitors
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
WO2012140642A1 (en) * 2011-04-10 2012-10-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
PT2834241T (pt) 2012-03-05 2021-02-05 Gilead Calistoga Llc Formas polimórficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenil quinazolina-4(3h)-ona
EP2870140B8 (en) 2012-07-09 2016-09-28 Lupin Limited Tetrahydroquinazolinone derivatives as parp inhibitors
EP3083623A1 (en) 2013-12-20 2016-10-26 Gilead Calistoga LLC Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
NZ736970A (en) 2013-12-20 2018-11-30 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
NZ726360A (en) 2014-06-13 2018-04-27 Gilead Sciences Inc Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249281B (enExample) * 1963-05-18

Also Published As

Publication number Publication date
BE768137A (fr) 1971-12-06
CH558374A (de) 1975-01-31
FR2100726A1 (enExample) 1972-03-24
CH557829A (de) 1975-01-15
AT317899B (de) 1974-09-25
NL7107695A (enExample) 1971-12-07
AT318628B (de) 1974-11-11
US3984555A (en) 1976-10-05
GB1331522A (en) 1973-09-26
FR2100726B1 (enExample) 1975-10-10
DE2027645A1 (de) 1971-12-09
CA951319A (en) 1974-07-16
AT318615B (de) 1974-11-11
LU63267A1 (enExample) 1972-08-23

Similar Documents

Publication Publication Date Title
FR2100726B1 (enExample)
FR2096336A5 (enExample)
AU3613471A (enExample)
FR2093899A5 (enExample)
FR2090926A5 (enExample)
FR2092586A5 (enExample)
FR2092112A1 (enExample)
FR2096428A1 (enExample)
FR2092444A5 (enExample)
FR2095889A5 (enExample)
FR2092308A5 (enExample)
FR2096398A1 (enExample)
FR2095922A5 (enExample)
FR2091655A5 (enExample)
FR2095940A5 (enExample)
FR2091683A5 (enExample)
FR2092100A1 (enExample)
FR2092116B1 (enExample)
FR2093873A5 (enExample)
FR2096311A5 (enExample)
FR2093954A1 (enExample)
FR2092035B1 (enExample)
FR2090613A5 (enExample)
FR2091922B1 (enExample)
FR2092185A5 (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased